Herbert Boyer

Herb BoyerHerbert W. BoyerHerbert W Boyer
Herbert Wayne "Herb" Boyer (born July 10, 1936) is a researcher and entrepreneur in biotechnology.wikipedia
86 Related Articles

Genetic engineering

genetically engineeredgenetic modificationgenetically modified
Along with Stanley N. Cohen and Paul Berg he discovered a method to coax bacteria into producing foreign proteins, thereby jump starting the field of genetic engineering.
The first GMO was a bacterium generated by Herbert Boyer and Stanley Cohen in 1973.

Genentech

Genentech, Inc.gene.comGenentech Inc Political Action Committee
He is recipient of the 1990 National Medal of Science, co-recipient of the 1996 Lemelson–MIT Prize, and a co-founder of Genentech. In 1976, Boyer founded Genentech with venture capitalist Robert A. Swanson.
The company was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Herbert Boyer.

Genetically modified bacteria

transgenic bacteriabacteriumgenetically modified bacterium
In August 1978, he produced synthetic insulin using his new transgenic genetically modified bacteria, followed in 1979 by a growth hormone.
The first example of this occurred in 1978 when Herbert Boyer, working at a University of California laboratory, took a version of the human insulin gene and inserted into the bacterium Escherichia coli to produce synthetic "human" insulin.

Saint Vincent College

Saint VincentSt. Vincent CollegeSt. Vincent's College
He received his bachelor's degree in biology and chemistry from Saint Vincent College in Latrobe, Pennsylvania, in 1958.
Herbert Boyer

Robert A. Swanson

Robert SwansonBob SwansonGenentech
In 1976, Boyer founded Genentech with venture capitalist Robert A. Swanson. 2000 Biotechnology Heritage Award with Robert A. Swanson, from the Biotechnology Industry Organization (BIO) and the Chemical Heritage Foundation
Robert "Bob" Swanson (1947–1999) was an American venture capitalist who cofounded the biotechnology giant Genentech in 1976 with Herbert Boyer.

City of Hope National Medical Center

City of HopeThe City of HopeThe City of Hope Foundation
In 1977, Boyer's laboratory and collaborators Keiichi Itakura and Arthur Riggs at City of Hope National Medical Center described the first-ever synthesis and expression of a peptide-coding gene.
In 1978, City of Hope researchers Arthur Riggs and Keiichi Itakura, working with Herbert Boyer of San Francisco-based biotechnology corporation Genentech, Inc., became the first scientists to produce synthetic human insulin.

Stanley Norman Cohen

Stanley CohenStanley N. Cohen
Along with Stanley N. Cohen and Paul Berg he discovered a method to coax bacteria into producing foreign proteins, thereby jump starting the field of genetic engineering. 2004 Albany Medical Center Prize (shared with Stanley N. Cohen)
Stanley Cohen and Herbert Boyer were the first scientists to transplant genes from one living organism to another, a fundamental discovery for genetic engineering.

University of California, San Francisco

UCSFUC San FranciscoUniversity of California San Francisco
He was professor at the University of California, San Francisco (UCSF) and later served as Vice President of Genentech from 1976 until his retirement in 1991.
Herbert Boyer, National Medal of Science (1990) and Shaw prize 2004, cofounder of Genentech

Shaw Prize

Shaw Prize in AstronomyShaw Prize in life science and medicineShaw
2004 Shaw Prize in Life Science and Medicine
Two inaugural prizes were awarded for the Life Science and Medicine category: Americans Stanley Norman Cohen, Herbert Boyer and Yuet-Wai Kan jointly won one of the prizes for their works pertaining to DNA while British physiologist Sir Richard Doll won the other for his contribution to cancer epidemiology.

IRI Achievement Award

Achievement Award
1982 the Industrial Research Institute (IRI) Achievement Award

National Medal of Technology and Innovation

National Medal of TechnologyNational Medals of TechnologyTechnology
1989 the National Medal of Technology

Derry, Pennsylvania

DerryDerry, corner of western PennsylvaniaDerry Borough
Hebert Boyer was born in 1936 in Derry, corner of western Pennsylvania where railroads and mines were the destiny of most young men.
Herbert Boyer, chemist and co-founder of Genentech

Keiichi Itakura

In 1977, Boyer's laboratory and collaborators Keiichi Itakura and Arthur Riggs at City of Hope National Medical Center described the first-ever synthesis and expression of a peptide-coding gene.
By 1978 Herbert Boyer's biotechnology startup Genentech had contracted with Riggs and Itakura, and Boyer and Itakura had created a plasmid coded for human insulin.

Lemelson–MIT Prize

Lemelson-MIT Student PrizeLemelson-MIT Lifetime Achievement AwardLemelson–MIT Student Prize
He is recipient of the 1990 National Medal of Science, co-recipient of the 1996 Lemelson–MIT Prize, and a co-founder of Genentech.
Herbert Boyer (Co-recipient, Lemelson–MIT Prize) for the development of methods to combine and transplant genes.

Albert Lasker Award for Basic Medical Research

Lasker AwardAlbert Lasker Basic Medical Research AwardAlbert Lasker Award
1980 the Albert Lasker Award for Basic Medical Research

Arthur Riggs (geneticist)

Arthur Riggs
In 1977, Boyer's laboratory and collaborators Keiichi Itakura and Arthur Riggs at City of Hope National Medical Center described the first-ever synthesis and expression of a peptide-coding gene.
Riggs and Itakura collaborated with Herbert Boyer at Genentech, and used recombinant DNA technology to become the first to produce a human protein in E. coli.

Scripps Research

The Scripps Research InstituteScrippsScripps Research Institute
Among his professional activities, Boyer is on the Board of Directors of Scripps Research.
The board of directors includes Herb Boyer (co-founder of Genentech), John D. Diekman (founder of 5AM Ventures), William R. Hearst III (Chairman of the Board, Hearst Corporation), Ge Li (Founder of WuXi AppTec), and Joel S. Marcus (Founder, Alexandria Real Estate Equities, Inc.).

University of Pittsburgh

PittsburghPittWestern University of Pennsylvania
He received his PhD at the University of Pittsburgh in 1963 and participated as an activist in the civil rights movement.
National Medal of Science winners include Bert W. O'Malley '59 & '63, a pioneer in steroid hormones, and Herbert Boyer '63, Genentech founder and biotech pioneer; while Leonard Baker '52 and Michael Chabon '84 have won the Pulitzer Prize.

Insulin

insulin geneinsulin signalinginsulin response
In August 1978, he produced synthetic insulin using his new transgenic genetically modified bacteria, followed in 1979 by a growth hormone.
The first genetically engineered, synthetic "human" insulin was produced using E. coli in 1978 by Arthur Riggs and Keiichi Itakura at the Beckman Research Institute of the City of Hope in collaboration with Herbert Boyer at Genentech.

Biotechnology Heritage Award

2000 Biotechnology Heritage Award with Robert A. Swanson, from the Biotechnology Industry Organization (BIO) and the Chemical Heritage Foundation
Herbert Boyer and Robert A. Swanson, 2000

Albany Medical Center Prize

2004 Albany Medical Center Prize (shared with Stanley N. Cohen)
Herbert W. Boyer

History of genetic engineering

Genetic engineering as the direct transfer of DNA from one organism to another was first accomplished by Herbert Boyer and Stanley Cohen in 1972.

Recombinant DNA

recombinantrecombinant proteingene splicing
Recombinant DNA in a living organism was first achieved in 1973 by Herbert Boyer, of the University of California at San Francisco, and Stanley Cohen, at Stanford University, who used E. coli restriction enzymes to insert foreign DNA into plasmids.

List of inventors

inventorInventors
Herbert Boyer (born 1936), together with Paul Berg (1926–), and Stanley Norman Cohen (1935–), U.S. – created first Genetically modified organism

Genetically modified organism containment and escape

coexistenceseed contaminantcoexistence of conventional and organic agriculture
The first use of Recombinant DNA (rDNA) technology had just been successfully accomplished by Stanley Cohen and Herbert Boyer two years previously and the scientific community recognized that as well as benefits this technology could also pose some risks.